TWIST1 and breast cancer: Twist expression in breast cancer cells has been shown to result in resistance to paclitaxel through binding to Akt promoter and enhancement of its transcriptional activity [26], as well as resistance to other microtubule-targeting agents such as vincristine [27,28].